Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling

Mathilde Marie Winkler Wille(Nordsjællands Hospital), Jesper Holst Pedersen(Reykjavík Energy (Iceland)), Zaigham Saghir(Gentofte Hospital), Klaus Richter Larsen(Bispebjerg Hospital), John Brodersen(University of Copenhagen), Niels Seersholm, Asger Dirksen, Jakob Fraes Rasmussen(University of Copenhagen), Jann Mortensen(Copenhagen University Hospital), Philip Tønnesen(Gentofte Hospital), Paul Frost Clementsen(Gentofte Hospital), Laura H. Thomsen(Respiratory Clinical Trials), Birgit Guldhammer Skov(Gentofte Hospital), Hanne Helene Hansen(University of Copenhagen), Karen Bach(Gentofte Hospital), Haseem Ashraf(University of Oslo)
American Journal of Respiratory and Critical Care Medicine
October 20, 2015
10.1164/rccm.201505-1040oc
Cited by 343

Related Papers

Detection and characterization of lung cancer using cell-free DNA fragmentomes
|Nature Communications|2021|458
The Danish Randomized Lung Cancer CT Screening Trial—Overall Design and Results of the Prevalence Round
|Journal of Thoracic Oncology|2009|440
CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT
|Thorax|2012|391
Overdiagnosis: what it is and what it isn’t
|BMJ Evidence-Based Medicine|2018|368
Long-Term Psychosocial Consequences of False-Positive Screening Mammography
|The Annals of Family Medicine|2013|342